Zheng Xing Xing Ye Ri Bao·2025-11-20 09:09Market Overview - The pharmaceutical commercial sector experienced a decline of 0.51% on November 20, with Renmin Tongtai leading the drop [1] - The Shanghai Composite Index closed at 3931.05, down 0.4%, while the Shenzhen Component Index closed at 12980.82, down 0.76% [1] Stock Performance - Notable gainers included: - HeFu China (603122) with a closing price of 26.18, up 10.00% [1] - KaiKai Industry (600272) at 14.58, up 4.14% [1] - Zhejiang Zhenyuan (000705) at 9.91, up 1.64% [1] - Major decliners included: - Renmin Tongtai (600829) at 14.36, down 9.97% [2] - Jianfa Zhixin (301584) at 32.34, down 4.88% [2] - Shuyupingmin (301017) at 13.40, down 3.11% [2] Capital Flow - The pharmaceutical commercial sector saw a net outflow of 260 million yuan from institutional investors, while retail investors had a net inflow of 264 million yuan [2] - The overall capital flow indicates a shift in investor sentiment, with retail investors showing more interest in the sector [2] Individual Stock Capital Flow - Shanghai Pharmaceuticals (601607) had a net inflow of 36.98 million yuan from institutional investors, but a net outflow from retail investors [3] - KaiKai Industry (600272) also saw a net inflow from institutional investors of 27.76 million yuan, with retail investors showing a net outflow [3] - Other stocks like Zhejiang Zhenyuan (000705) and Dajia Weikang (301126) experienced mixed capital flows, indicating varied investor interest [3]